Attached files
| file | filename |
|---|---|
| EX-5.1 - OPINION ON LEGALITY - AzurRx BioPharma, Inc. | ex5-1.htm |
| S-1/A - AMENDMENT NO. 1 - AzurRx BioPharma, Inc. | azrxs1-am1_july2017.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We
hereby consent to the incorporation by reference in this Prospectus
constituting part of the Registration Statement on the Amendment
No. 1 to Form S-1 (No. 333-219385) of our report dated March 31,
2017, related to the consolidated financial statements of AzurRx
BioPharma, Inc. as of December 31, 2016 and 2015 and for the years
then ended, which appears in the Annual Report on Form 10-K of
AzurRx BioPharma, Inc. for the year ended December 31, 2016. The
report for AzurRx BioPharma, Inc. includes an explanatory paragraph
about the existence of substantial doubt concerning its ability to
continue as a going concern. We also consent to the reference to
our Firm under the caption “Experts” in such
Prospectus.
/s/ Mazars USA LLP
New
York, New York
August
8, 2017